Internal Medicine, Nephrology · Crestview, FL
NPI
1740269448
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
221 E Redstone Ave
Crestview, FL, 32539
Phone (850) 444-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$386K
5,686 services
Medicare patients, 2024
907
Average age 76
Drug cost, 2024
$816K
6,412 prescriptions
Company payments, 2025
$19.23
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles B Arbogast was code 99214 (office e&m - established), 1,673 times for 800 patients. In total Charles B Arbogast billed 5,686 services in 38 codes, and Medicare paid $386K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,673 | 800 | $94.28 | $158K |
| J0897 Injection, denosumab, 1 mg | Office | 1,140 | 17 | $18.86 | $22K |
| 99232 Hospital E&M - Subsequent | Facility | 464 | 88 | $64.98 | $30K |
| 99458 E&M - Miscellaneous | Office | 392 | 44 | $31.89 | $13K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 303 | 51 | $48.14 | $15K |
| 99457 E&M - Miscellaneous | Office | 274 | 48 | $39.38 | $11K |
| 90935 Hemodialysis | Facility | 158 | 33 | $57.73 | $9,121 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 134 | 134 | $135.81 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 120 | 117 | $7.33 | $880 |
| 99454 E&M - Miscellaneous | Office | 103 | 32 | $36.63 | $3,773 |
| 99204 Office E&M - New | Office | 103 | 103 | $118.17 | $12K |
| 90961 ESRD Related Services (not dialysis) | Office | 98 | 27 | $230.28 | $23K |
| 99213 Office E&M - Established | Office | 95 | 91 | $53.61 | $5,092 |
| 90960 ESRD Related Services (not dialysis) | Office | 89 | 21 | $295.73 | $26K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 73 | 28 | $40.14 | $2,930 |
By year: 2022 $366K for 5,300 services; 2023 $348K for 5,512 services; 2024 $386K for 5,686 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charles B Arbogast prescribed most often to Medicare patients was Calcitriol, with 770 prescriptions and refills. In total Charles B Arbogast wrote 6,412 Medicare prescriptions that cost $816K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 770 | 2,047 | 212 | $16K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 223 | 587 | 66 | $3,089 |
| Hydralazine Hcl Generic | 211 | 608 | 68 | $3,811 |
| Atorvastatin Calcium Generic | 193 | 511 | 58 | $1,717 |
| Levothyroxine Sodium Generic | 188 | 525 | 53 | $1,816 |
| Losartan Potassium Generic | 185 | 530 | 55 | $1,805 |
| Amlodipine Besylate Generic | 158 | 438 | 48 | $1,147 |
| Furosemide Generic | 156 | 404 | 53 | $839 |
| Metoprolol Succinate Generic | 134 | 374 | 41 | $1,880 |
| Metoprolol Tartrate Generic | 117 | 336 | 34 | $990 |
| Omeprazole Generic | 101 | 243 | 25 | $1,675 |
| Nifedipine Er Nifedipine | 97 | 264 | 29 | $3,831 |
| Alprazolam Generic | 94 | 98 | 15 | $349 |
| Rosuvastatin Calcium Generic | 89 | 241 | 23 | $837 |
| Cinacalcet Hcl Generic | 88 | 191 | 29 | $30K |
Brand drugs: 817 claims; generic drugs: 5,555 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles B Arbogast $19.23 ($19.23 in general payments such as food, travel and fees) from 1 company. The largest payer was Calliditas Therapeutics US Inc. with $19.23.
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 1 | $19.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.